Indivior Pharmaceuticals (INDV) Market Capitalization (2021 - 2026)

Indivior Pharmaceuticals has reported Market Capitalization for 6 years, with the latest figure at $4.8 billion in Q2 2026.

• On a quarterly basis, Market Capitalization rose 163.29% year-over-year to $4.8 billion in Q2 2026; TTM through Jun 2026 was $4.8 billion, a 163.29% increase from a year earlier, with the FY2025 full-year figure at $4.5 billion, up 189.6% from the prior year.
• Market Capitalization was $4.8 billion for Q2 2026 at Indivior Pharmaceuticals, up from $3.7 billion in the prior quarter.
• The five-year high for Market Capitalization was $4.8 billion in Q2 2026, with the low at $1.2 billion in Q1 2025.
• Average Market Capitalization over 5 years is $2.7 billion, with a median of $2.5 billion recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Market Capitalization plunged 59.18% in 2025, then soared 212.53% in 2026.
• Over 5 years, Market Capitalization stood at $3.0 billion in 2022, then retreated by 29.77% to $2.1 billion in 2023, then slipped by 25.68% to $1.5 billion in 2024, then jumped by 189.6% to $4.5 billion in 2025, then gained by 7.91% to $4.8 billion in 2026.
• The last three Market Capitalization figures came in at $4.8 billion (Q2 2026), $3.7 billion (Q1 2026), and $4.5 billion (Q4 2025), per Business Quant data.